» Articles » PMID: 31241921

Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by Ru--Cymene Complexes of Trimethoxyaniline-Based Schiff Bases

Overview
Journal Inorg Chem
Specialty Chemistry
Date 2019 Jun 27
PMID 31241921
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Four trimethoxy- and dimethoxyphenylamine-based Schiff base ()-bearing Ru--cymene complexes () of the chemical formula [Ru(η--cymene)(L)(Cl)] were synthesized, isolated in pure form, and structurally characterized using single-crystal X-ray diffraction and other analytical techniques. The complexes showed excellent antiproliferative activity against various forms of cancer that are difficult to cure, viz., triple negative human metastatic breast carcinoma MDA-MB-231, human pancreatic carcinoma MIA PaCa-2, and hepatocellular carcinoma Hep G2. The H nuclear magnetic resonance data in the presence of 10% dimethylformamide- or dimethyl sulfoxide- in phosphate buffer (pD 7.4, containing 4 mM NaCl) showed that the complexes immediately generate the aquated species that is stable for at least 24 h. Electrospray ionization mass spectrometry data showed that they do not bind with guanine nitrogen even in the presence of 5 molar equivalents of 9-EtG, during a period of 24 h. The best complex in the series, , exhibits an IC of approximately 10-15 μM in the panel of tested cancer cell lines. The complexes do not enhance the production of reactive oxygen species in the cells. Docking studies with a tubulin crystal structure (Protein Data Bank entry 1SAO ) revealed that and as well as and have a high affinity for the interface of the α and β tubulin dimer in the colchicine binding site. The immunofluorescence studies showed that and strongly inhibited microtubule network formation in MDA-MB-231 cells after treatment with an IC or IC dose for 12 h. The cell cycle analysis upon treatment with showed that the complexes inhibit the mitotic phase because the arrest was observed in the G2/M phase. In summary, and are Ru half-sandwich complexes that are capable of disrupting a microtubule network in a dose-dependent manner. They depolarize the mitochondria, arrest the cell cycle in the G2/M phase, and kill the cells by an apoptotic pathway.

Citing Articles

Exploring the Potential of Metal-Based Candidate Drugs as Modulators of the Cytoskeleton.

Borutzki Y, Skos L, Gerner C, Meier-Menches S Chembiochem. 2023; 24(17):e202300178.

PMID: 37345897 PMC: 10946712. DOI: 10.1002/cbic.202300178.


Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes.

Wittmann C, Sivchenko A, Bacher F, Tong K, Guru N, Wilson T Inorg Chem. 2022; 61(3):1456-1470.

PMID: 34995063 PMC: 8790753. DOI: 10.1021/acs.inorgchem.1c03154.


Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.

Lee S, Kim C, Nam T Drug Des Devel Ther. 2020; 14:5375-5392.

PMID: 33299303 PMC: 7721113. DOI: 10.2147/DDDT.S275007.


Is the Way to Fight Cancer Paved with Gold? Metal-Based Carbene Complexes with Multiple and Fascinating Biological Features.

Iacopetta D, Rosano C, Sirignano M, Mariconda A, Ceramella J, Ponassi M Pharmaceuticals (Basel). 2020; 13(5).

PMID: 32403274 PMC: 7281280. DOI: 10.3390/ph13050091.


Dual-Action Ru(II) Complexes with Bulky π-Expansive Ligands: Phototoxicity without DNA Intercalation.

Toupin N, Nadella S, Steinke S, Turro C, Kodanko J Inorg Chem. 2020; 59(6):3919-3933.

PMID: 32096986 PMC: 7539634. DOI: 10.1021/acs.inorgchem.9b03585.

References
1.
Peacock A, Sadler P . Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents. Chem Asian J. 2008; 3(11):1890-9. DOI: 10.1002/asia.200800149. View

2.
Leijen S, Burgers S, Baas P, Pluim D, Tibben M, van Werkhoven E . Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy. Invest New Drugs. 2014; 33(1):201-14. DOI: 10.1007/s10637-014-0179-1. View

3.
Prinz H, Ridder A, Vogel K, Bohm K, Ivanov I, Ghasemi J . N-Heterocyclic (4-Phenylpiperazin-1-yl)methanones Derived from Phenoxazine and Phenothiazine as Highly Potent Inhibitors of Tubulin Polymerization. J Med Chem. 2017; 60(2):749-766. DOI: 10.1021/acs.jmedchem.6b01591. View

4.
Peacock A, Habtemariam A, Fernandez R, Walland V, Fabbiani F, Parsons S . Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J Am Chem Soc. 2006; 128(5):1739-48. DOI: 10.1021/ja055886r. View

5.
Zeng L, Gupta P, Chen Y, Wang E, Ji L, Chao H . The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. Chem Soc Rev. 2017; 46(19):5771-5804. PMC: 5624840. DOI: 10.1039/c7cs00195a. View